申请人:Merrell Dow Pharmaceuticals Inc.
公开号:US05028614A1
公开(公告)日:1991-07-02
The present invention describes a group of polyhydroxylated indolizidines and quinolizidines and their esters. These compounds are prepared starting from 2,6-dideoxy-2,6-dideoxy-2,6-imino-1,3,4,5-tetrakis-O- (phenylmethyl)-D-glycero-L-gulo-heptitol or a corresponding N-substituted compound. The compounds are useful in the treatment of diabetes and as .alpha.-glucosidase I inhibitors.
本发明描述了一组多羟基吲哚啉和喹哚啉及其酯类。这些化合物是从2,6-二脱氧-2,6-二脱氧-2,6-亚胺-1,3,4,5-四-O-(苯甲基)-D-甘露-L-戊醇或相应的N-取代化合物开始制备的。这些化合物在糖尿病治疗和作为α-葡萄糖苷酶I抑制剂方面是有用的。